Zhao W - Search Results

1

Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial.

Zhu J, Zhao W, Liang D, Li G, Qiu K, Wu J, Li J. Zhu J, et al. Among authors: zhao w. Int J Clin Oncol. 2018 Apr;23(2):389-399. doi: 10.1007/s10147-017-1218-7. Epub 2017 Nov 27. Int J Clin Oncol. 2018. PMID: 29181651

2

Meta-analysis of randomized controlled trials for the incidence and risk of fatal adverse events in cancer patients treated with ipilimumab.

Zhu J, Wu J, Li G, Li J, Lin Y, He Z, Su C, Zhao W, Wu Q, Chen Z, Qiu K. Zhu J, et al. Among authors: zhao w. Expert Opin Drug Saf. 2017 Apr;16(4):423-428. doi: 10.1080/14740338.2017.1297420. Epub 2017 Feb 24. Expert Opin Drug Saf. 2017. PMID: 28276859

3

Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map.

Zhu J, Yu X, Zheng Y, Li J, Wang Y, Lin Y, He Z, Zhao W, Chen C, Qiu K, Wu J. Zhu J, et al. Among authors: zhao w. Lancet Diabetes Endocrinol. 2020 Mar;8(3):192-205. doi: 10.1016/S2213-8587(19)30422-X. Epub 2020 Jan 29. Lancet Diabetes Endocrinol. 2020. PMID: 32006518

4

Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database.

Gao S, He Z, Zhu J, Liang D, Zhao W, Yang S, Jiang W, Qiu K, Yu X, Wu J. Gao S, et al. Among authors: zhao w. Pharmacoepidemiol Drug Saf. 2022 Nov;31(11):1199-1205. doi: 10.1002/pds.5493. Epub 2022 Jul 6. Pharmacoepidemiol Drug Saf. 2022. PMID: 35689298

5

Type 1 diabetes with immune checkpoint inhibitors: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing data.

Zhu J, Luo M, Liang D, Gao S, Zheng Y, He Z, Zhao W, Yu X, Qiu K, Wu J. Zhu J, et al. Among authors: zhao w. Int Immunopharmacol. 2022 Sep;110:109053. doi: 10.1016/j.intimp.2022.109053. Epub 2022 Jul 21. Int Immunopharmacol. 2022. PMID: 35978507

6

SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.

He Z, Lam K, Zhao W, Yang S, Li Y, Mo J, Gao S, Liang D, Qiu K, Huang M, Wu J. He Z, et al. Among authors: zhao w. Acta Diabetol. 2023 Mar;60(3):401-411. doi: 10.1007/s00592-022-02015-6. Epub 2022 Dec 28. Acta Diabetol. 2023. PMID: 36576563

7

Three-dimensional pharmacophore modeling of liver-X receptor agonists.

Zhao W, Gu Q, Wang L, Ge H, Li J, Xu J. Zhao W, et al. J Chem Inf Model. 2011 Sep 26;51(9):2147-55. doi: 10.1021/ci100511v. Epub 2011 Mar 24. J Chem Inf Model. 2011. PMID: 21434646

8

A new protocol for predicting novel GSK-3β ATP competitive inhibitors.

Fang J, Huang D, Zhao W, Ge H, Luo HB, Xu J. Fang J, et al. Among authors: zhao w. J Chem Inf Model. 2011 Jun 27;51(6):1431-8. doi: 10.1021/ci2001154. Epub 2011 Jun 9. J Chem Inf Model. 2011. PMID: 21615159

9

Mechanistic studies for tri-targeted inhibition of enzymes involved in cholesterol biosynthesis by green tea polyphenols.

Ge H, Liu J, Zhao W, Wang Y, He Q, Wu R, Li D, Xu J. Ge H, et al. Among authors: zhao w. Org Biomol Chem. 2014 Jul 21;12(27):4941-51. doi: 10.1039/c4ob00589a. Org Biomol Chem. 2014. PMID: 24879560

10

Porous Pt-Ni-P composite nanotube arrays: highly electroactive and durable catalysts for methanol electrooxidation.

Ding LX, Wang AL, Li GR, Liu ZQ, Zhao WX, Su CY, Tong YX. Ding LX, et al. J Am Chem Soc. 2012 Apr 4;134(13):5730-3. doi: 10.1021/ja212206m. Epub 2012 Mar 20. J Am Chem Soc. 2012. PMID: 22404702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,285 results

Search Page

Filters